Loading clinical trials...
Loading clinical trials...
Safety evaluation of Intra-Coronary Administration of MCRcI® stem cells in Patients with Diffuse Coronary Artery Disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Honya Medical Inc
Collaborators
NCT07324720 · Coronary Artery Disease
NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more
NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease
NCT05770349 · Heart Failure, Coronary Artery Disease
NCT06779630 · Coronary Artery Disease
HONYA Medical Inc
Tainan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions